ImpediMed Reaches Milestone of 500,000 Patient Tests Performed with the SOZO Digital Health Platform
CARLSBAD, Calif., Nov. 2, 2022 /PRNewswire/ -- ImpediMed Limited (ASX: IPD) reached a milestone of 500,000 patient tests performed with the SOZO Digital Health Platform.
- CARLSBAD, Calif., Nov. 2, 2022 /PRNewswire/ -- ImpediMed Limited (ASX: IPD) reached a milestone of 500,000 patient tests performed with the SOZO Digital Health Platform.
- With over 1,100 devices in use globally, the pace of patient testing has accelerated with 100,000 patient tests performed in just the past six months.
- "Reaching 500,000 patient tests is an important milestone and positive indicator of the future health of our business.
- The SOZO Digital Health Platform launched in 2017 and improvements delivered with four generations of software advancements have led to increased adoption and utilization every year.